We are live on ! Find out more
MAM

McCarthy Asset Management Portfolio holdings

AUM $192M
1-Year Est. Return 10.3%
This Fund
S&P 500
This Quarter Est. Return
+10.24%
1 Year Est. Return
+10.3%
3 Year Est. Return
+40.15%
5 Year Est. Return
+51.88%
10 Year Est. Return
–
AUM
$121M
AUM Growth
–
Cap. Flow
+$116M
Cap. Flow %
95.92%
Top 10 Hldgs %
79.65%
Holding
392
New
391
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$20.4M
2
VIG icon
Vanguard Dividend Appreciation ETF
VIG
+$19.6M
3
SCHD icon
Schwab US Dividend Equity ETF
SCHD
+$17.1M
4
GILD icon
Gilead Sciences
GILD
+$10.4M
5
AAPL icon
Apple
AAPL
+$6.21M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 10.81%
2 Technology 7.17%
3 Consumer Discretionary 4.01%
4 Financials 3.65%
5 Communication Services 2.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VCEL icon
351
Vericel Corp
VCEL
$2.36B
$0 ﹤0.01%
+400
New +$9.52K
VHC icon
352
VirnetX Holding Corp
VHC
$56.8M
$0 ﹤0.01%
+5
New +$540
XLK icon
353
State Street Technology Select Sector SPDR ETF
XLK
$117B
$0 ﹤0.01%
+2
New +$122
XPRO icon
354
Expro Ltd
XPRO
$1.79B
$0 ﹤0.01%
+17
New +$222
ZBH icon
355
Zimmer Biomet
ZBH
$18.8B
$0 ﹤0.01%
+2
New +$282
BIMI
356
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
$0 ﹤0.01%
+2
New +$187
AIRC
357
DELISTED
Apartment Income REIT Corp.
AIRC
$0 ﹤0.01%
+5
New +$192
PLAN
358
DELISTED
Anaplan, Inc.
PLAN
$0 ﹤0.01%
+1
New +$65
BMY.RT
359
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$0 ﹤0.01%
+639
New +$1.36K
BTX.WS
360
DELISTED
BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
$0 ﹤0.01%
+14
New –
DD
361
DELISTED
Du Pont De Nemours E I
DD
$0 ﹤0.01%
+6
New –
NT
362
DELISTED
NORTEL NETWORKS CRP(HLDG CO) NEW
NT
$0 ﹤0.01%
+10
New –
BAY
363
DELISTED
BAYER AG SPONS ADR
BAY
$0 ﹤0.01%
+10
New –
TBUS
364
DELISTED
DRI CORPORATION COMN STK (NC)
TBUS
$0 ﹤0.01%
+2,000
New –
CHU
365
DELISTED
China Unicom (HONG KONG) Limited
CHU
$0 ﹤0.01%
+80
New +$506
VVUS
366
DELISTED
Vivus Inc
VVUS
$0 ﹤0.01%
+160
New –
AST
367
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$0 ﹤0.01%
+12
New –
AST.WS
368
DELISTED
Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017)
AST.WS
$0 ﹤0.01%
+2
New –
NWBO
369
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$0 ﹤0.01%
+232
New –
CHBT
370
DELISTED
China-Biotics, Inc. Common Stock
CHBT
$0 ﹤0.01%
+360
New –
AV
371
DELISTED
Aviva Plc
AV
$0 ﹤0.01%
+35
New –
11 12 13 14
15

Similar funds

NWM
NRI Wealth Management Santa Clara, California $196M AUM 32.41% 1-Year Est. Return
PSB
Passumpsic Savings Bank St. Johnsbury, Vermont $183M AUM
CIC
Cornercap Investment Counsel Atlanta, Georgia $203M AUM 17.67% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM

McCarthy Asset Management's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for McCarthy Asset Management, which disclosed 392 positions worth $121M. Its ten largest holdings account for 80% of the portfolio.

Its largest position is JPMorgan Ultra-Short Income ETF: 400,827 shares worth $20.4M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, followed by Technology and Consumer Discretionary.

  • McCarthy Asset Management's largest Q4 2020 buy was JPMorgan Ultra-Short Income ETF: 400,827 shares worth $20.4M.
  • McCarthy Asset Management's ten largest holdings make up 80% of its $121M portfolio in Q4 2020.
  • McCarthy Asset Management disclosed 392 positions in Q4 2020, its first 13F filing on record.

Based on McCarthy Asset Management's 13F filing for Q4 2020, filed 1 Feb 2021.